STAT3 and chondrosarcoma: Jin et al. indicated that treatment with SIRT1 agonist resveratrol in vitro induced apoptosis, inhibited proliferation, and affected phosphorylation within the STAT3 signaling pathway by activating Sirt1 in SW1353 chondrosarcoma cells47.